TIM-3 in Alzheimer's treatment has emerged as a groundbreaking focus in Alzheimer's disease research, opening up new avenues for therapy.This immune checkpoint molecule, previously recognized for its role in cancer therapy, is now being investigated to enhance cognitive improvement in Alzheimer's patients.